Adicet Bio
ACET
ACET
98 hedge funds and large institutions have $177M invested in Adicet Bio in 2024 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 39 increasing their positions, 14 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
27% more funds holding
Funds holding: 77 → 98 (+21)
7.7% more ownership
Funds ownership: 83.78% → 91.48% (+7.7%)
Holders
98
Holding in Top 10
–
Calls
$109K
Puts
$65K
Top Buyers
| 1 | +$17.7M | |
| 2 | +$14.5M | |
| 3 | +$13M | |
| 4 |
Goldman Sachs
New York
|
+$9.35M |
| 5 |
O
OrbiMed
New York
|
+$7.34M |
Top Sellers
| 1 | -$4.36M | |
| 2 | -$3.6M | |
| 3 | -$762K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$480K |
| 5 |
OQS
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
|
-$144K |